Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.71
+0.33 (3.52%)
At close: Feb 26, 2026, 4:00 PM EST
7.88
-1.83 (-18.85%)
After-hours: Feb 26, 2026, 6:14 PM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $551.88 million as of February 26, 2026. Its market cap has decreased by -16.02% in one year.
Market Cap
551.88M
Enterprise Value
512.89M
1-Year Change
-16.02%
Ranking
Category
Stock Price
$9.71
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $551.88M, a decrease of -74.71%. That is a compound annual growth rate of -24.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 551.88M | 16.85% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 603.28M |
| Alto Neuroscience | 599.27M |
| Fulcrum Therapeutics | 581.42M |
| CorMedix | 579.10M |
| Contineum Therapeutics | 576.43M |
| Altimmune | 558.53M |
| Forte Biosciences | 521.75M |
| Zevra Therapeutics | 511.74M |